MedTrace Logo

Effect of VR on Pain and Patient Satisfaction in Adults Receiving GNRFA

NCT05468398 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-05-22

Study results available
· View outcomes & findings →

Summary

The study team aims to investigate whether implementing virtual reality therapy (VRT) during Genicular nerve radiofrequency ablation (GNRFA) procedure will provide better alleviation of procedural pain and augmented satisfaction for patients.

Conditions

  • Pain
  • Patient Satisfaction

Interventions

DEVICE

Soothe VR

The Soothe VR system is manufactured by Applied VR. It is a HIPAA-compliant platform and has been validated by randomized control trials. It has not yet been reviewed by the FDA.

Sponsors & Collaborators

  • Applied VR

    collaborator UNKNOWN

  • University of California, Irvine

    lead OTHER

Principal Investigators

  • Navid Alem, MD · Faculty

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-02
Primary Completion
2024-09-06
Completion
2024-12-14
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05468398 on ClinicalTrials.gov